Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:list
Public health concept |
| gptkbp:alsoKnownAs |
gptkb:WHO_Model_List_of_Essential_Medicines
|
| gptkbp:category |
gptkb:Antibiotics
Vaccines Anticancer medicines Medicines for chronic diseases Medicines for infectious diseases Medicines for mental and behavioral disorders Medicines for reproductive health Pain and palliative care medicines |
| gptkbp:contains |
Medicines considered most effective and safe to meet important needs
|
| gptkbp:criteria |
Comparative cost-effectiveness
Evidence on efficacy and safety Public health relevance |
| gptkbp:firstPublished |
1977
|
| https://www.w3.org/2000/01/rdf-schema#label |
Essential medicine (WHO)
|
| gptkbp:includes |
Complementary list
Core list |
| gptkbp:influenced |
National essential medicines lists
|
| gptkbp:latestReleaseVersion |
2023
|
| gptkbp:maintainedBy |
gptkb:World_Health_Organization
|
| gptkbp:purpose |
Guide national health systems on priority medicines
|
| gptkbp:relatedTo |
gptkb:WHO_Model_List_of_Essential_Medicines_for_Children
|
| gptkbp:updated |
Every two years
|
| gptkbp:usedBy |
Countries worldwide
|
| gptkbp:website |
https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines
|
| gptkbp:bfsParent |
gptkb:clarithromycin
gptkb:montelukast |
| gptkbp:bfsLayer |
6
|